Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Association of transanal minimally invasive surgical approach with oncologic outcomes over conventional transanal excision for early-stage rectal cancer: An analysis of the US Rectal Cancer Consortium.
Authors
Emilie Warren
Emory University, Atlanta, GA;
Emilie Warren , Adriana C. Gamboa , Caroline Medin , Samantha Hendren , Scott E. Regenbogen , Jennifer Holder-Murray , Matthew Kalady , Aslam Ejaz , Alexander Hawkins , Paul Wise , Matthew Silviera , Shishir K. Maithel , Glen C. Balch
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Therapeutics
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 145)
DOI
10.1200/JCO.2023.41.4_suppl.145
Abstract #
145
Poster Bd #
H4
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Local excision to enhance organ preservation in rectal cancer after favorable response to total neoadjuvant therapy.
First Author: Aron Bercz
Poster
2023 ASCO Annual Meeting
Laparoscopic versus open-surgery in FIGO stage II endometrioid endometrium cancers: Is there a prognostic effect?
First Author: Daniel Uwe Reimer
Poster
2023 ASCO Annual Meeting
Decision value of the circulating tumor DNA on the adjuvant anti-Her2 regimens in patients with Her2-positive breast cancer treated with neoadjuvant therapy.
First Author: Po-Han Lin
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Neoadjuvant chemoradiation does not improve outcomes for patients undergoing resection for upper rectal cancer: A US Rectal Cancer Consortium analysis.
First Author: Caroline Medin